Simona Soverini, C.D.B. (2013). Ultra Deep Sequencing (UDS) Allows More Sensitive Detection Of Tyrosine Kinase Inhibitor (TKI)-Resistant BCR-ABL Mutations That Would Influence Therapeutic Decision At The Time Of Switchover To Second- Or Third-Line Therapy. BLOOD, 122(21), 380-380 [10.1182/blood.V122.21.380.380].
Ultra Deep Sequencing (UDS) Allows More Sensitive Detection Of Tyrosine Kinase Inhibitor (TKI)-Resistant BCR-ABL Mutations That Would Influence Therapeutic Decision At The Time Of Switchover To Second- Or Third-Line Therapy
Simona Soverini;Caterina De Benedittis;Fausto Castagnetti;Gabriele Gugliotta;Francesca Palandri;Cristina Papayannidis;Ilaria Iacobucci;Claudia Venturi;Manuela Mancini;Elisa Leo;Stefania Paolini;Domenico Russo;Gianantonio Rosti;Michele Baccarani;Michele Cavo;Giovanni Martinelli
2013
File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.